2010
Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations
Bilgüvar K, Öztürk A, Louvi A, Kwan KY, Choi M, Tatlı B, Yalnızoğlu D, Tüysüz B, Çağlayan A, Gökben S, Kaymakçalan H, Barak T, Bakırcıoğlu M, Yasuno K, Ho W, Sanders S, Zhu Y, Yılmaz S, Dinçer A, Johnson MH, Bronen RA, Koçer N, Per H, Mane S, Pamir MN, Yalçınkaya C, Kumandaş S, Topçu M, Özmen M, Šestan N, Lifton RP, State MW, Günel M. Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 2010, 467: 207-210. PMID: 20729831, PMCID: PMC3129007, DOI: 10.1038/nature09327.Peer-Reviewed Original ResearchConceptsAbnormal cortical developmentWD repeat domain 62 (WDR62) geneSevere brain malformationsWhole-exome sequencingBrain abnormalitiesBrain malformationsCortical developmentMolecular pathogenesisCerebellar hypoplasiaWDR62 mutationsEmbryonic neurogenesisDiagnostic classificationMicrocephaly genesSmall family sizeGenetic heterogeneityWide spectrumRecessive mutationsPachygyriaPathogenesisHypoplasiaNeocortexNeurogenesisAbnormalitiesMalformationsMutations
2004
Neuroimaging of the cortical dysplasias
Ruggieri P, Najm I, Bronen R, Campos M, Cendes F, Duncan J, Weiser H, Theodore W. Neuroimaging of the cortical dysplasias. Neurology 2004, 62: s27-s29. PMID: 15037675, DOI: 10.1212/01.wnl.0000117581.46053.18.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
1994
Quantitative MR for epilepsy: a clinical and research tool?
Bronen R, Anderson A, Spencer D. Quantitative MR for epilepsy: a clinical and research tool? American Journal Of Neuroradiology 1994, 15: 1157-60. PMID: 8073987, PMCID: PMC8333470.Commentaries, Editorials and Letters
1990
Magnetic resonance imaging contrast agents: theory and application to the central nervous system.
Bronen R, Sze G. Magnetic resonance imaging contrast agents: theory and application to the central nervous system. Journal Of Neurosurgery 1990, 73: 820-39. PMID: 2230966, DOI: 10.3171/jns.1990.73.6.0820.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCentral nervous systemComputerized tomographyMR imagingNervous systemContrast-enhanced computerized tomographyActive multiple sclerosisIntradural spinal neoplasmsSecondary brain tumorsCerebral blood flowContrast-enhanced MR imagingContrast agentsIntrathecal contrast mediumStudy of choiceMagnetic resonanceMagnetic resonance imagingSignal intensity changesCNS lesionsMultiple sclerosisPituitary lesionsPostoperative stateAcoustic neurinomaSpinal neoplasmsMore abnormalitiesBlood flowSpinal disease
1989
MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis.
Sze G, Soletsky S, Bronen R, Krol G. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. American Journal Of Neuroradiology 1989, 10: 965-75. PMID: 2505542, PMCID: PMC8335283.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overBrainBrain DiseasesCarcinomaChildChild, PreschoolContrast MediaFemaleGadoliniumGadolinium DTPAHumansImage EnhancementInfantMagnetic Resonance ImagingMaleMeningeal NeoplasmsMeningesMiddle AgedOrganometallic CompoundsPentetic AcidProspective StudiesRadiographyRetrospective StudiesConceptsContrast-enhanced CTAbnormal meningeal enhancementMeningeal carcinomatosisMeningeal enhancementInner tableMR imagingGroup of patientsDiffuse meningeal enhancementContrast-enhanced MRAbnormal findingsLeptomeningeal tumorSubdural hematomaInflammatory conditionsGroup 2Postoperative defectsGroup 1CarcinomatosisSkull lesionsGroup 3Pathologic conditionsNormal meningesMeningesPatientsCranial meningesHead scans